BOYLE SCOTT N (Chief Business Officer) received a stock award from C4 THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/18/2026ACC: 0001470831-26-000180
Officer· Chief Business Officer
Since Mar 2022
+216.95K
Net shares
Net buyer
$17.0K
Total sold
0
Open market trades
0B · 0S
5
Total transactions
225.95K acquired · 9K disposed
Non-Derivative Transactions5
Common Stock
Direct
Shares
+200K
Price / share
—
Trade value
—
% of position
185.5%
2/13/2026
107.81K→307.81K
Common Stock
Direct
Shares
+5K
Price / share
—
Trade value
—
% of position
1.7%
2/13/2026
302.81K→307.81K
Common Stock
Direct
Shares
−1.74K
Price / share
$1.89
Trade value
$3.28K
% of position
0.6%
2/13/2026
307.81K→306.07K
Common Stock
Direct
Shares
+20.95K
Price / share
—
Trade value
—
% of position
7.3%
2/14/2026
285.12K→306.07K
Common Stock
Direct
Shares
−7.27K
Price / share
$1.89
Trade value
$13.74K
% of position
2.4%
2/14/2026
306.07K→298.80K
Total
Net shares
+216.95K
Net value
-$17.02K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/13/2026 | A · Award | +200K | — | — | 185.5% | 107.81K | 307.81K |
| Common Stock Direct | 2/13/2026 | M · Option Exercise | +5K | — | — | 1.7% | 302.81K | 307.81K |
| Common Stock Direct | 2/13/2026 | F · Tax Withholding | −1.74K | $1.89 | $3.28K | 0.6% | 307.81K | 306.07K |
| Common Stock Direct | 2/14/2026 | M · Option Exercise | +20.95K | — | — | 7.3% | 285.12K | 306.07K |
| Common Stock Direct | 2/14/2026 | F · Tax Withholding | −7.27K | $1.89 | $13.74K | 2.4% | 306.07K | 298.80K |
| Total | +216.95K | -$17.02K | ||||||
Derivative Transactions0
No derivative transactions reported